Form D · Other Health Care

Novaestiq Corp.

Southlake, TX · CIK 0001877943

Offering snapshot reported Apr 17, 2024 · SEC filing

Reported sold: $7.35M
Investors reported: 56
Minimum accepted: $0
First sale: Jul 30, 2021

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$3,830,448 → $7,350,948
Reported investors23 → 56

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Apr 17, 2024	Amendment	$7,350,948	$3,520,500vs Dec 20, 2023	56	SEC filing
Dec 20, 2023	Amendment	$3,830,448	$3,530,350vs Sep 22, 2021	23	SEC filing
Oct 5, 2021	Initial	$28,020	No comparison	1	SEC filing
Sep 22, 2021	Amendment	$300,098	$150,098vs Aug 17, 2021	6	SEC filing
Aug 17, 2021	Initial	$150,000	No comparison	1	SEC filing

Offering details

Securities: Debt, Option to acquire, Security to be acquired
Exemptions: 06b
Duration over one year: Yes
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-410241

Sales compensation recipients

Scroll to see all columns →

Recipient	CRD	Associated broker-dealer
Issuer Direct Sales Only	None

Source: Form D, filed Apr 17, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Humberto Antunes	Director, Executive
Miles David Harrison	Director, Executive
Andreas Prinz	Director
Ethan Rigel	Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:

1560 East Southlake Boulevard
Southlake, TX, 76092